Literature DB >> 24816281

Secreted phosphoprotein 1 is a determinant of lung function development in mice.

Koustav Ganguly1, Timothy M Martin, Vincent J Concel, Swapna Upadhyay, Kiflai Bein, Kelly A Brant, Leema George, Ankita Mitra, Tania A Thimraj, James P Fabisiak, Louis J Vuga, Cheryl Fattman, Naftali Kaminski, Holger Schulz, George D Leikauf.   

Abstract

Secreted phosphoprotein 1 (Spp1) is located within quantitative trait loci associated with lung function that was previously identified by contrasting C3H/HeJ and JF1/Msf mouse strains that have extremely divergent lung function. JF1/Msf mice with diminished lung function had reduced lung SPP1 transcript and protein during the peak stage of alveologenesis (postnatal day [P]14-P28) as compared with C3H/HeJ mice. In addition to a previously identified genetic variant that altered runt-related transcription factor 2 (RUNX2) binding in the Spp1 promoter, we identified another promoter variant in a putative RUNX2 binding site that increased the DNA protein binding. SPP1 induced dose-dependent mouse lung epithelial-15 cell proliferation. Spp1((-/-)) mice have decreased specific total lung capacity/body weight, higher specific compliance, and increased mean airspace chord length (Lm) compared with Spp1((+/+)) mice. Microarray analysis revealed enriched gene ontogeny categories, with numerous genes associated with lung development and/or respiratory disease. Insulin-like growth factor 1, Hedgehog-interacting protein, wingless-related mouse mammary tumor virus integration site 5A, and NOTCH1 transcripts decreased in the lung of P14 Spp1((-/-)) mice as determined by quantitative RT-PCR analysis. SPP1 promotes pneumocyte growth, and mice lacking SPP1 have smaller, more compliant lungs with enlarged airspace (i.e., increased Lm). Microarray analysis suggests a dysregulation of key lung developmental transcripts in gene-targeted Spp1((-/-)) mice, particularly during the peak phase of alveologenesis. In addition to its known roles in lung disease, this study supports SPP1 as a determinant of lung development in mice.

Entities:  

Keywords:  asthma; chronic obstructive pulmonary disease; emphysema; osteopontin; pulmonary fibrosis

Mesh:

Substances:

Year:  2014        PMID: 24816281      PMCID: PMC4224082          DOI: 10.1165/rcmb.2013-0471OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  117 in total

1.  Superoxide dismutases, lung function and bronchial responsiveness in a general population.

Authors:  M Siedlinski; C C van Diemen; D S Postma; J M Vonk; H M Boezen
Journal:  Eur Respir J       Date:  2009-02-12       Impact factor: 16.671

2.  Lung function and airway diseases.

Authors:  Scott T Weiss
Journal:  Nat Genet       Date:  2010-01       Impact factor: 38.330

3.  Superoxide dismutase 3, extracellular (SOD3) variants and lung function.

Authors:  Koustav Ganguly; Martin Depner; Cheryl Fattman; Kiflai Bein; Tim D Oury; Scott C Wesselkamper; Michael T Borchers; Martina Schreiber; Fei Gao; Erika von Mutius; Michael Kabesch; George D Leikauf; Holger Schulz
Journal:  Physiol Genomics       Date:  2009-03-24       Impact factor: 3.107

4.  Notch signaling controls the balance of ciliated and secretory cell fates in developing airways.

Authors:  Po-Nien Tsao; Michelle Vasconcelos; Konstantin I Izvolsky; Jun Qian; Jining Lu; Wellington V Cardoso
Journal:  Development       Date:  2009-07       Impact factor: 6.868

5.  Loss of Erk3 function in mice leads to intrauterine growth restriction, pulmonary immaturity, and neonatal lethality.

Authors:  Sonia Klinger; Benjamin Turgeon; Kim Lévesque; Geoffrey A Wood; Kjersti M Aagaard-Tillery; Sylvain Meloche
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-15       Impact factor: 11.205

6.  Age- and gender-specific modulation of serum osteopontin and interferon-alpha by osteopontin genotype in systemic lupus erythematosus.

Authors:  S N Kariuki; J G Moore; K A Kirou; M K Crow; T O Utset; T B Niewold
Journal:  Genes Immun       Date:  2009-04-02       Impact factor: 2.676

7.  Early life origins of chronic obstructive pulmonary disease.

Authors:  C Svanes; J Sunyer; E Plana; S Dharmage; J Heinrich; D Jarvis; R de Marco; D Norbäck; C Raherison; S Villani; M Wjst; K Svanes; J M Antó
Journal:  Thorax       Date:  2009-09-02       Impact factor: 9.139

8.  Adenosine and osteopontin contribute to the development of chronic obstructive pulmonary disease.

Authors:  Daniel J Schneider; Janci C Lindsay; Yang Zhou; Jose G Molina; Michael R Blackburn
Journal:  FASEB J       Date:  2009-08-31       Impact factor: 5.191

9.  Genome-wide association study identifies five loci associated with lung function.

Authors:  Emmanouela Repapi; Ian Sayers; Louise V Wain; Paul R Burton; Toby Johnson; Ma'en Obeidat; Jing Hua Zhao; Adaikalavan Ramasamy; Guangju Zhai; Veronique Vitart; Jennifer E Huffman; Wilmar Igl; Eva Albrecht; Panos Deloukas; John Henderson; Raquel Granell; Wendy L McArdle; Alicja R Rudnicka; Inês Barroso; Ruth J F Loos; Nicholas J Wareham; Linda Mustelin; Taina Rantanen; Ida Surakka; Medea Imboden; H Erich Wichmann; Ivica Grkovic; Stipan Jankovic; Lina Zgaga; Anna-Liisa Hartikainen; Leena Peltonen; Ulf Gyllensten; Asa Johansson; Ghazal Zaboli; Harry Campbell; Sarah H Wild; James F Wilson; Sven Gläser; Georg Homuth; Henry Völzke; Massimo Mangino; Nicole Soranzo; Tim D Spector; Ozren Polasek; Igor Rudan; Alan F Wright; Markku Heliövaara; Samuli Ripatti; Anneli Pouta; Asa Torinsson Naluai; Anna-Carin Olin; Kjell Torén; Matthew N Cooper; Alan L James; Lyle J Palmer; Aroon D Hingorani; S Goya Wannamethee; Peter H Whincup; George Davey Smith; Shah Ebrahim; Tricia M McKeever; Ian D Pavord; Andrew K MacLeod; Andrew D Morris; David J Porteous; Cyrus Cooper; Elaine Dennison; Seif Shaheen; Stefan Karrasch; Eva Schnabel; Holger Schulz; Harald Grallert; Nabila Bouatia-Naji; Jérôme Delplanque; Philippe Froguel; John D Blakey; John R Britton; Richard W Morris; John W Holloway; Debbie A Lawlor; Jennie Hui; Fredrik Nyberg; Marjo-Riitta Jarvelin; Cathy Jackson; Mika Kähönen; Jaakko Kaprio; Nicole M Probst-Hensch; Beate Koch; Caroline Hayward; David M Evans; Paul Elliott; David P Strachan; Ian P Hall; Martin D Tobin
Journal:  Nat Genet       Date:  2009-12-13       Impact factor: 38.330

10.  Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function.

Authors:  Dana B Hancock; Mark Eijgelsheim; Jemma B Wilk; Sina A Gharib; Laura R Loehr; Kristin D Marciante; Nora Franceschini; Yannick M T A van Durme; Ting-Hsu Chen; R Graham Barr; Matthew B Schabath; David J Couper; Guy G Brusselle; Bruce M Psaty; Cornelia M van Duijn; Jerome I Rotter; André G Uitterlinden; Albert Hofman; Naresh M Punjabi; Fernando Rivadeneira; Alanna C Morrison; Paul L Enright; Kari E North; Susan R Heckbert; Thomas Lumley; Bruno H C Stricker; George T O'Connor; Stephanie J London
Journal:  Nat Genet       Date:  2009-12-13       Impact factor: 41.307

View more
  9 in total

1.  Sexual dimorphism of the pulmonary transcriptome in neonatal hyperoxic lung injury: identification of angiogenesis as a key pathway.

Authors:  Cristian Coarfa; Yuhao Zhang; Suman Maity; Dimuthu N Perera; Weiwu Jiang; Lihua Wang; Xanthi Couroucli; Bhagavatula Moorthy; Krithika Lingappan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-17       Impact factor: 5.464

2.  Genetic Strain and Sex Differences in a Hyperoxia-Induced Mouse Model of Varying Severity of Bronchopulmonary Dysplasia.

Authors:  Sean Leary; Pragnya Das; Devasena Ponnalagu; Harpreet Singh; Vineet Bhandari
Journal:  Am J Pathol       Date:  2019-02-19       Impact factor: 4.307

3.  Homeobox, Wnt, and Fibroblast Growth Factor Signaling is Augmented During Alveogenesis in Mice Lacking Superoxide Dismutase 3, Extracellular.

Authors:  Tania A Thimraj; Rahel L Birru; Ankita Mitra; Holger Schulz; George D Leikauf; Koustav Ganguly
Journal:  Lung       Date:  2017-02-20       Impact factor: 2.584

4.  Transcriptomic analysis comparing mouse strains with extreme total lung capacities identifies novel candidate genes for pulmonary function.

Authors:  Leema George; Ankita Mitra; Tania A Thimraj; Martin Irmler; Sangeetha Vishweswaraiah; Lars Lunding; Dorothea Hühn; Alicia Madurga; Johannes Beckers; Heinz Fehrenbach; Swapna Upadhyay; Holger Schulz; George D Leikauf; Koustav Ganguly
Journal:  Respir Res       Date:  2017-08-09

5.  A candidate gene identification strategy utilizing mouse to human big-data mining: "3R-tenet" in COPD genetic research.

Authors:  Sangeetha Vishweswaraiah; Leema George; Natarajan Purushothaman; Koustav Ganguly
Journal:  Respir Res       Date:  2018-06-06

6.  Impaired Glucocorticoid Receptor Dimerization Aggravates LPS-Induced Circulatory and Pulmonary Dysfunction.

Authors:  Martin Wepler; Jonathan M Preuss; Tamara Merz; Clair Hartmann; Ulrich Wachter; Oscar McCook; Josef Vogt; Sandra Kress; Michael Gröger; Marina Fink; Angelika Scheuerle; Peter Möller; Enrico Calzia; Ute Burret; Peter Radermacher; Jan P Tuckermann; Sabine Vettorazzi
Journal:  Front Immunol       Date:  2020-01-23       Impact factor: 7.561

7.  Interleukin-38 ameliorates poly(I:C) induced lung inflammation: therapeutic implications in respiratory viral infections.

Authors:  Xun Gao; Paul Kay Sheung Chan; Grace Chung Yan Lui; David Shu Cheong Hui; Ida Miu-Ting Chu; Xiaoyu Sun; Miranda Sin-Man Tsang; Ben Chung Lap Chan; Christopher Wai-Kei Lam; Chun-Kwok Wong
Journal:  Cell Death Dis       Date:  2021-01-07       Impact factor: 8.469

8.  Secreted Phosphoprotein 1 and Sex-Specific Differences in Silica-Induced Pulmonary Fibrosis in Mice.

Authors:  Joseph D Latoche; Alexander Chukwuma Ufelle; Fabrizio Fazzi; Koustav Ganguly; George D Leikauf; Cheryl L Fattman
Journal:  Environ Health Perspect       Date:  2016-03-08       Impact factor: 9.031

9.  Inflammatory Signals Induce AT2 Cell-Derived Damage-Associated Transient Progenitors that Mediate Alveolar Regeneration.

Authors:  Jinwook Choi; Jong-Eun Park; Georgia Tsagkogeorga; Motoko Yanagita; Bon-Kyoung Koo; Namshik Han; Joo-Hyeon Lee
Journal:  Cell Stem Cell       Date:  2020-08-03       Impact factor: 24.633

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.